Skip to content

Discontinued — last reported Q4 '25

Free cash flow at other companies

CVS Health logo
CVS HealthCVS
$3.4B-10.8%
Omnicell logo
OmnicellOMCL
$42.07M+185%
PACS Group logo
PACS GroupPACS
$214.51M+61.9%
Cencora logo
CencoraCOR
-$2.42B+14.2%
Cardinal Health logo
Cardinal HealthCAH
$1.68B-40.0%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG

Other financials

Income statement

See full
Revenue$336.6M+2.2%
Gross profit$76.3M+18.6%
Operating income$17.7M+35.9%
Net income$13.3M+40.7%
EPS (diluted)$0.21+40.0%

Balance sheet

See full
Cash & equivalents$64.9M+364%
Total debt$36.9M+29.6%
Total equity$232.4M+42.4%
Total assets$426.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M-65.5%
CapEx$495.0K-78.0%

Valuation

See full
Market cap$2.48B+80.1%
Enterprise value$2.45B+76.1%
P/E46.8×
P/S1.7×+0.6×

Profitability

See full
Gross margin20.9%+1.1pp
Operating margin5.3%
Net margin3.6%+2.1pp

Returns & leverage

See full
Return on equity26.8%
Debt / equity0.2×0.0×
Current ratio1.5×+0.3×

Where this comes from

Calculated from Guardian Pharmacy Services’s reported figures.

The official record: Guardian Pharmacy Services’s 10-K, filed March 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardian Pharmacy Services's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Guardian Pharmacy Services's free cash flow?
Guardian Pharmacy Services (GRDN) reported free cash flow of $34.11M in Q4 2025.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.